12:00 AM
 | 
Feb 14, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Enbrel etanercept soluble TNF receptor regulatory update

IMNX received EU marketing approval for Enbrel to treat active rheumatoid arthritis (RA) in patients with an...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >